Augmedics raises $82.5 million Series D for AR spine surgery system
The Israeli startup’s xvision Spine System allows surgeons to see patients’ anatomy as if they have “x-ray vision” and accurately navigate instruments and implants during spine procedures
Augmedics, which develops augmented reality (AR) surgical navigation solutions, announced the successful close of an $82.5 million Series D financing round. The round was led by Dallas-based CPMG and adds Evidity Health Capital as a syndicate partner, with participation from current investors H.I.G. Capital, Revival Healthcare Capital, Almeda Ventures and others.
Full list of Israeli high-tech funding rounds in 2023
Augmedics, founded in 2014 by Nissan Elimelech, employs around 100 people, half of them at its offices in Yokneam. The company took its total funding to date to $145 million.
Augmedics’ xvision Spine System allows surgeons to see patients’ anatomy as if they have “x-ray vision” and accurately navigate instruments and implants during spine procedures. The FDA-cleared xvision has been used to treat over 4,000 patients and implant more than 20,000 pedicle screws across 21 U.S. states. xvision has consistently demonstrated 97-100% accuracy of pedicle screw placement across multiple patient studies.
Related articles:
“To close an $82.5M round in the current fundraising environment is a testament to the dramatic impact Augmedics is making on the field of spine surgery. The accomplishment is underscored by the tremendous achievement of 4,000 patient lives impacted,” said Augmedics President and CEO Kevin Hykes.
